These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 19927767
1. [Enzyme replacement therapy for Gaucher paediatric disease: the only Tunisian experience]. Ben Turkia H, Azzouz H, Tebib N, Abdelmoula MS, Ben Chehida A, Hlel Y, Caillaud C, Sahli H, Ben Dridi MF. Tunis Med; 2009 May; 87(5):344-8. PubMed ID: 19927767 [Abstract] [Full Text] [Related]
2. Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase. Smith L, Rhead W, Charrow J, Shankar SP, Bavdekar A, Longo N, Mardach R, Harmatz P, Hangartner T, Lee HM, Crombez E, Pastores GM. Mol Genet Metab; 2016 Feb; 117(2):164-71. PubMed ID: 26043810 [Abstract] [Full Text] [Related]
3. Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1. Andersson H, Kaplan P, Kacena K, Yee J. Pediatrics; 2008 Dec; 122(6):1182-90. PubMed ID: 19047232 [Abstract] [Full Text] [Related]
4. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI]. Tóth J, Szücs FZ, Benkö K, Maródi L. Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625 [Abstract] [Full Text] [Related]
5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease]. Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM. Zhonghua Er Ke Za Zhi; 2006 Sep 20; 44(9):653-6. PubMed ID: 17217655 [Abstract] [Full Text] [Related]
6. [French results of enzyme replacement therapy in Gaucher's disease]. Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM. Bull Acad Natl Med; 2002 Sep 20; 186(5):851-61; discussion 861-3. PubMed ID: 12412377 [Abstract] [Full Text] [Related]
7. Bone complications in children with Gaucher disease. Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ. Br J Radiol; 2002 Sep 20; 75 Suppl 1():A37-44. PubMed ID: 12036831 [Abstract] [Full Text] [Related]
8. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, Rosen BR, Baker J, Niklason LT, Hill SC. Pediatrics; 1995 Oct 20; 96(4 Pt 1):629-37. PubMed ID: 7567322 [Abstract] [Full Text] [Related]
9. Type I Gaucher disease in children with and without enzyme therapy. Dweck A, Abrahamov A, Hadas-Halpern I, Bdolach-Avram T, Zimran A, Elstein D. Pediatr Hematol Oncol; 2002 Sep 20; 19(6):389-97. PubMed ID: 12186361 [Abstract] [Full Text] [Related]
10. Enzyme replacement therapy for Gaucher Disease: the only experience in Malaysia. Chan LL, Lin HP. Med J Malaysia; 2002 Sep 20; 57(3):348-52. PubMed ID: 12440275 [Abstract] [Full Text] [Related]
11. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients. El-Beshlawy A, Ragab L, Youssry I, Yakout K, El-Kiki H, Eid K, Mansour IM, Abd El-Hamid S, Yang M, Mistry PK. J Inherit Metab Dis; 2006 Feb 20; 29(1):92-8. PubMed ID: 16601874 [Abstract] [Full Text] [Related]
12. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease. Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, Hangartner TN. J Bone Miner Res; 2007 Jan 20; 22(1):119-26. PubMed ID: 17032149 [Abstract] [Full Text] [Related]
13. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response? Arikan-Ayyildiz Z, Yüce A, Emre S, Baysoy G, Saltik-Temizel IN, Gürakan F. Turk J Pediatr; 2011 Jan 20; 53(5):499-507. PubMed ID: 22272449 [Abstract] [Full Text] [Related]
14. [Phenotype and mutational spectrum in Tunisian pediatric gaucher disease]. Ben Turkia H, Riahi I, Azzouz H, Ladab S, Cherif W, Ben Chehida A, Abdelmoula MS, Caillaud C, Chemli J, Abdelhak S, Tebib N, Ben Dridi MF. Tunis Med; 2010 Mar 20; 88(3):158-62. PubMed ID: 20415187 [Abstract] [Full Text] [Related]
15. Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement. Elstein D, Hadas-Halpern I, Itzchaki M, Lahad A, Abrahamov A, Zimran A. Blood Cells Mol Dis; 1996 Mar 20; 22(2):104-11; discussion 112-4. PubMed ID: 8931951 [Abstract] [Full Text] [Related]
16. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease. Lin HY, Lin SP, Chuang CK, Wraith JE. J Chin Med Assoc; 2006 May 20; 69(5):228-32. PubMed ID: 16835986 [Abstract] [Full Text] [Related]
17. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW. Blood Cells Mol Dis; 2000 Aug 20; 26(4):285-90. PubMed ID: 11042029 [Abstract] [Full Text] [Related]
18. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy. Tezuka Y, Fukuda M, Watanabe S, Nakano T, Okamoto K, Kuzume K, Yano Y, Eguchi M, Ishimae M, Ishii E, Miyazaki T. Blood Cells Mol Dis; 2018 Feb 20; 68():194-199. PubMed ID: 27866810 [Abstract] [Full Text] [Related]
19. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement]. Poll LW, vom Dahl S, Koch JA, Börner D, Willers R, Cohnen M, Jung G, Scherer A, Niederau C, Häussinger D, Mödder U. Rofo; 2001 Oct 20; 173(10):931-7. PubMed ID: 11588682 [Abstract] [Full Text] [Related]
20. Pediatric Gaucher experience in South Marmara region of Turkey. Erdemır G, Özkan T, Özgür T, Yazici Z, Özdemır Ö. Turk J Gastroenterol; 2011 Oct 20; 22(5):500-4. PubMed ID: 22234757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]